Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
10 clinical trials · Condition
◉ Watch Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
| Record | Firm | Date |
|---|---|---|
| Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry (NCT05430971) | Immune Oncology Research Institute | 2022-07-01 |
| Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product. (NCT05645744) | Mustang Bio | 2021-09-29 |
| Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN. (NCT04109482) | Mustang Bio | 2020-02-17 |
| Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies (NCT04013685) | Orca Biosystems, Inc. | 2019-11-21 |
| Combination Chemotherapy in Patients With Newly Diagnosed BPDCN (NCT03599960) | Centre Hospitalier Universitaire de Besancon | 2019-05-02 |
| Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia (NCT02113982) | Stemline Therapeutics, Inc. | 2014-09-01 |
Track Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) automatically
Every clearance here is in the API, with alerts when new ones post.